<DOC>
	<DOCNO>NCT01346592</DOCNO>
	<brief_summary>This Study Aims Evaluate Safety , Tolerability , Immunogenicity Adjuvanted Trivalent Subunit Influenza Vaccine Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared Non-Adjuvanted Trivalent Split Influenza Vaccine Children 6 &lt; 72 Months Age .</brief_summary>
	<brief_title>Safety , Tolerability , Immunogenicity Adjuvanted Trivalent Subunit Influenza Vaccine Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared Non-Adjuvanted Trivalent Split Influenza Vaccine Children 6 &lt; 72 Months Age</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1.Children 6 month 72 month age . Children 1. Who hospitalize time enrollment 2. Who serious reaction hypersensitivity vaccine component , egg , chicken protein 3. Who know impairment immune function 4. Who fever interfere normal daily activity time enrollment 5. Who receive licensed vaccine within 14 day ( inactivated vaccine ) 28 day ( live vaccine ) prior enrollment study 6 . Concomitant participation another clinical study 7. Who surgery plan study period investigator 's opinion would interfere study visit schedule .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Adjuvanted Trivalent Subunit Influenza Vaccine</keyword>
	<keyword>vaccine</keyword>
	<keyword>influenza</keyword>
	<keyword>adjuvant</keyword>
	<keyword>MF-59</keyword>
	<keyword>pediatric</keyword>
</DOC>